ATOS icon

Atossa Therapeutics
ATOS

Overview Fund Activity

54 hedge funds and large institutions have $11.9M invested in Atossa Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
15
Closed
6
Calls
$779K
Puts
$82K
Net Calls
+$697K
Net Calls Change
-$594K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$915K
2
Connor, Clark & Lunn Investment Management (CC&L)
2
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$98.4K
3
XT
3
XTX Topco
Cayman Islands
$123K
4
Two Sigma Investments
4
Two Sigma Investments
New York
$128K
5
Group One Trading
5
Group One Trading
Illinois
$96.3K

Top Sellers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$183K
3
Millennium Management
3
Millennium Management
New York
$177K
4
Jane Street
4
Jane Street
New York
$12.7K
5
Morgan Stanley
5
Morgan Stanley
New York
$110K
Name Holding Trade Value Shares
Change 		Shares
Change %
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
– -$273K -216,528 Closed
Wolverine Trading
52
Wolverine Trading
Illinois
– -$24K -18,734 Closed
CAN
53
Cetera Advisor Networks
California
– -$16.8K -13,332 Closed
BBA
54
Baader Bank Aktiengesellschaft
Germany
– -$10.6K -10,861 Closed
DFCM
55
Dark Forest Capital Management
Puerto Rico
– -$12.8K -10,193 Closed
Citigroup
56
Citigroup
New York
– -$214 -170 Closed
1 2
3